1. Wang, Xingang, Zheng, Yan, Wang, Yu. 2021. PEAK1 promotes invasion and metastasis and confers drug resistance in breast cancer. In Clinical and experimental medicine, 22, 393-402. doi:10.1007/s10238-021-00761-5. https://pubmed.ncbi.nlm.nih.gov/34554318/
2. Agajanian, Megan, Campeau, Anaamika, Hoover, Malachia, Klemke, Richard L, Kelber, Jonathan A. 2015. PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer. In PloS one, 10, e0135748. doi:10.1371/journal.pone.0135748. https://pubmed.ncbi.nlm.nih.gov/26267863/
3. Pan, Min, Yin, Xiaohui, Huang, Yi-Chuan. . Pseudopodium enriched atypical kinase 1(PEAK1) promotes invasion and of melanoma cells by activating JAK/STAT3 signals. In Bioengineered, 12, 5045-5055. doi:10.1080/21655979.2021.1961661. https://pubmed.ncbi.nlm.nih.gov/34365903/
4. Wang, Qiuhan, Hao, Fengyun, Ning, Liang, Sun, Chong. 2024. Targeting PEAK1 sensitizes anaplastic thyroid carcinoma cells harboring BRAFV600E to Vemurafenib by Bim upregulation. In Histology and histopathology, 39, 1159-1165. doi:10.14670/HH-18-705. https://pubmed.ncbi.nlm.nih.gov/38284248/
5. Agajanian, Megan, Runa, Farhana, Kelber, Jonathan A. 2015. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer. In Biochemical and biophysical research communications, 465, 606-12. doi:10.1016/j.bbrc.2015.08.071. https://pubmed.ncbi.nlm.nih.gov/26297948/
6. Ding, Chenbo, Tang, Wendong, Wu, Hailu, Wen, Kunming, Wu, Guoqiu. 2018. The PEAK1-PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer. In Cancer letters, 442, 383-395. doi:10.1016/j.canlet.2018.11.014. https://pubmed.ncbi.nlm.nih.gov/30472186/
7. Huang, Lanlan, Wen, Chuangyu, Yang, Xiangling, Wang, Jianping, Liu, Huanliang. 2018. PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d. In Cell death & disease, 9, 271. doi:10.1038/s41419-018-0320-8. https://pubmed.ncbi.nlm.nih.gov/29449544/